/Tag:non-Hodgkins lymphoma

Cancer Drug Developed by UAMS Professor Receives FDA Approval

Sept. 24, 2013 | Valchlor, a breakthrough gel for treating lymphoma developed with the help of University of Arkansas for Medical Sciences (UAMS) College of Pharmacy Professor Peter Crooks, Ph.D., recently won marketing approval from the U.S. Food and Drug Administration.

By | September 24th, 2013|UAMS News, University News|0 Comments

Cancer Drug Developed by UAMS Professor Awarded FDA Approval

LITTLE ROCK — Valchlor, a breakthrough gel for treating lymphoma developed with the help of University of Arkansas for Medical Sciences (UAMS) College of Pharmacy Professor Peter Crooks, Ph.D., recently won marketing approval from the U.S. Food and Drug Administration.

By | September 24th, 2013|Media Contact - Taylor/Caldwell, UAMS News|0 Comments